Summary
Simulations Plus, Inc. (Simulations Plus) is a software company that develops and markets software for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide and food ingredient industries. Its products include GastroPlus, ADMET Predictor, MedChem Studio, DDDPlus, MedChem Designer, ADMET Design Suite, Biorelevant Solubility Database and MembranePlus. The company also offers training workshops and consulting services. Simulations Plus is headquartered in Lancaster, California, the US.
Simulations Plus, Inc. (SLP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
                     
                                   '
                        
Table of Contents
Table of Contents  2
List of Tables  3
List of Figures  4
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Simulations Plus, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
Simulations Plus, Inc., Medical Devices Deals, 2010 to YTD 2016  9
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deal Details  11
Asset Purchase  11
Simulations Plus To Acquire Software Royalty Agreement From Enslein Research For US$0.8 Million  11
Partnerships  12
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases  12
Simulations Plus Enters Into Agreement With Pharma Company  13
Licensing Agreements  14
Simulations Plus Enters into Licensing Agreement with Dow Chemical  14
Simulations Plus Terminates Licensing Agreement with TSRL  15
Acquisition  16
Simulations Plus Acquires Cognigen for USD7 Million  16
Simulations Plus Terminates The Acquisition Of Entelos  17
Simulations Plus, Inc. - Key Competitors  18
Key Employees  19
Locations And Subsidiaries  20
Head Office  20
Other Locations & Subsidiaries  20
Appendix  21
Methodology  21
About GlobalData  21
Contact Us  21
Disclaimer  21
List of Tables
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015  1
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Simulations Plus, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Simulations Plus, Inc., Deals By Therapy Area, 2010 to YTD 2016  8
Simulations Plus, Inc., Medical Devices Deals, 2010 to YTD 2016  9
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
Simulations Plus To Acquire Software Royalty Agreement From Enslein Research For US$0.8 Million  11
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases  12
Simulations Plus Enters Into Agreement With Pharma Company  13
Simulations Plus Enters into Licensing Agreement with Dow Chemical  14
Simulations Plus Terminates Licensing Agreement with TSRL  15
Simulations Plus Acquires Cognigen for USD7 Million  16
Simulations Plus Terminates The Acquisition Of Entelos  17
Simulations Plus, Inc., Key Competitors  18
Simulations Plus, Inc., Key Employees  19
Simulations Plus, Inc., Subsidiaries  20
List of Figures
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  1
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  1
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  1
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  1
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  6
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Simulations Plus, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
Simulations Plus, Inc., Medical Devices Deals, 2010 to YTD 2016  9